Abstract
Background & Objective: Semiconductor quantum dots proved themselves as efficient fluorescent probes in cancer detection and treatment. Their size, high stability, non-photobleaching and water solubility made them a unique fluorophore in place of conventional organic dyes.
Method: Newly emerged theranostic drug delivery system using quantum dots helped us in better understanding of the drug delivery mechanism inside the cells. Surface modified Quantum dots and their applications became wide in bioimaging, immunohistochemistry, tracking intracellular drug and intracellular molecules target. Conclusion: We have highlighted various applications of quantum dots in cancer treatment, drug delivery, flow cytometry, and theranostics.Keywords: Bioimaging, fluorescence, quantum dots, targeted drug delivery, theranostics, tumor cells.
Graphical Abstract
Mini-Reviews in Medicinal Chemistry
Title:Current Application of Quantum Dots (QD) in Cancer Therapy: A Review
Volume: 17 Issue: 14
Author(s): Lavanya Thilak Babu and Priyankar Paira*
Affiliation:
- Department of Chemistry, School of Advanced Sciences, VIT University, Vellore-632014, Tamil Nadu,India
Keywords: Bioimaging, fluorescence, quantum dots, targeted drug delivery, theranostics, tumor cells.
Abstract: Background & Objective: Semiconductor quantum dots proved themselves as efficient fluorescent probes in cancer detection and treatment. Their size, high stability, non-photobleaching and water solubility made them a unique fluorophore in place of conventional organic dyes.
Method: Newly emerged theranostic drug delivery system using quantum dots helped us in better understanding of the drug delivery mechanism inside the cells. Surface modified Quantum dots and their applications became wide in bioimaging, immunohistochemistry, tracking intracellular drug and intracellular molecules target. Conclusion: We have highlighted various applications of quantum dots in cancer treatment, drug delivery, flow cytometry, and theranostics.Export Options
About this article
Cite this article as:
Babu Thilak Lavanya and Paira Priyankar*, Current Application of Quantum Dots (QD) in Cancer Therapy: A Review, Mini-Reviews in Medicinal Chemistry 2017; 17 (14) . https://dx.doi.org/10.2174/1389557517666170315125504
DOI https://dx.doi.org/10.2174/1389557517666170315125504 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy MicroRNAs and Cancer; an Overview
Current Pharmaceutical Biotechnology Ferroptosis Inducers for Prostate Cancer Therapy
Current Medicinal Chemistry Drugs Interfering with Apoptosis in Breast Cancer
Current Pharmaceutical Design Ionotropic Glutamate Receptors & CNS Disorders
CNS & Neurological Disorders - Drug Targets The Potential Role of Peritumoral Apparent Diffusion Coefficient Evaluation in Differentiating Glioblastoma and Solitary Metastatic Lesions of the Brain
Current Medical Imaging AZT: An Old Drug with New Perspectives
Current Clinical Pharmacology Protein Targeting Constructs in Alpha Therapy
Current Radiopharmaceuticals Brain Cancer-Activated Microglia: A Potential Role for Sphingolipids
Current Medicinal Chemistry Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
Current Protein & Peptide Science Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Current Genomics Targeted Drug Delivery for Breast Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status
Current Pharmaceutical Design Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Non-Covalent Proteasome Inhibitors
Current Pharmaceutical Design Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
Current Cancer Therapy Reviews Increased Neuronal Injury in Clock Gene Per-1 Deficient-Mice after Cerebral Ischemia
Current Neurovascular Research Lessons we Learned from High-Throughput and Top-Down Systems Biology Analyses about Glioma Stem Cells
Current Pharmaceutical Design